DBV Technologies | Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amarin USD -7.74M 6.4M 2025-09
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
DBV Technologies USD -33.16M 8.71M 2025-09
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Incyte USD 299.28M 124.89M 2025-12
Insmed USD -370.02M 48.34M 2025-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
PTC Therapeutics USD 15.9M 80.75M 2025-09
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09


DBV Technologies Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.